Payers and providers play an important role in addressing the opioid crisis in our communities. This page highlights the most recently added resources specifically targeting healthcare providers, healthcare system employees, and individuals who manage private and public insurance plans. These resources, identified with blue tiles, include patient and provider education materials, clinical practice guidelines and practice protocols, and research and reports about insurance coverage and benefit design around addiction treatment and pain management.
If you’d like to submit materials for inclusion consideration or suggest a future featured topic, please visit CLOUD’s call for submissions page.
Arizona adopted a law requiring all Arizona health care providers to use electronic prescribing for all Schedule II controlled substances by January 1, 2020. This 2 page document answers frequently asked questions about the electronic prescribing program.
Arizona adopted a law requiring all Arizona health care providers to use electronic prescribing for all Schedule II controlled substances by January 1, 2020. This one page document summarizes costs associated with adopting electronic prescribing of controlled substances in the most widely
Arizona adopted a law requiring all Arizona health care providers to use electronic prescribing for all Schedule II controlled substances by January 1, 2020. This one page fact sheet explains the new requirement and describes the benefits of electronic prescribing.
This 2016 report from The College of Psychiatric and Neurologic Pharmacists provides information for community pharmacists about opioid use disorder and how pharmacists can assist in efforts to reduce prescription misuse and treat opioid use disorder.
This 2015 guide to naloxone for the treatment of opioid overdoses from The College of Psychiatric and Neurologic Pharmacists includes information about the various forms of naloxone, briefly describes state and local naloxone distribution efforts, and includes sample patient information sheets.
This 2018 guideline from College of Psychiatric and Neurologic Pharmacists offers advice to pharmacists and providers about tapering patients off long term use of benzodiazepines. Patients prescribed both opioids and benzodiazepines are at higher risk of overdose and death.
This 2019 report from the American Medical Association’s Opioid Task Force includes recommendations for physicians and health care providers and policymakers in addressing the opioid epidemic.
This 2015 report from the Association for Community Affiliated Health Plans summarizes the findings from their reducing prescription drug abuse collaborative. The report describes projects designed and implemented by 13 participating health plans in the areas of screening, brief intervention, and referral to treatment (SBIRT);
The Center on Addiction website has resources for policymakers, health care providers, patients, and their families and caregivers on addiction related topics including prevention, treatment, and recovery. In 2019, the Center on Addiction and Partnership for Drug-Free Kids merged and
This 2018 report provides a comprehensive overview of opioid use disorder (OUD) in America from the perspective of the U.S. Surgeon General. Written for all audiences, it includes information about prevalence of OUD, a discussion of the neurobiology of addiction, the continuum of care for treatment, recovery options, and the role of health care systems in addressing the crisis.